Mission Statement
The Division of Microbiology and Infectious Diseases (DMID) supports extramural research—basic through applied—to control and prevent diseases caused by virtually all human infectious agents except HIV (see HIV/AIDS Information for Researchers).
Overview
DMID supports product development research in a variety of ways. NIAID funding opportunities and solicitations can provide financial support for a specific research area. DMID also offers product development services for each stage of the development pathway. These services include a suite of preclinical programs that are available to the scientific community. The preclinical programs support in-kind studies, conducted by NIAID-funded contractors, to provide gap-filling information and de-risk the development process. Capabilities of the preclinical programs include synthesis and manufacturing, in vitro and in vivo testing, and safety and pharmacology studies. DMID also maintains numerous publicly available resources to help support research and development activities, such as repositories for sharing reagents and other materials. Finally, advanced development programs entering clinical trials can explore DMID’s clinical trial programs and resources.
Highlights
Diagnostics Development Services
NIAID’s Diagnostics Development Services program offers a comprehensive array of in-kind services to in vitro diagnostics developers to accelerate progress toward regulatory clearance and commercial launch.
Plans and Profiles for Medical Countermeasures for Infectious Diseases
The generic product development plans and target product profiles provide guidance for the development of vaccines, small molecules, and monoclonal antibodies through early clinical evaluation.
Contact Your Program Officer to Discuss Opportunities
Contact DMID staff for more information about support mechanisms for product development programs.